Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS: EMMA · Delayed Price · USD
0.0713
-0.0317 (-30.78%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $4.55 million as of July 22, 2024. Its market cap has decreased by -61.41% in one year.
Market Cap
4.55M
Enterprise Value
35.11M
1-Year Change
-61.41%
Ranking
n/a
Category
Stock Price
$0.07
Market Cap Chart
Since July 14, 2017, Emmaus Life Sciences's market cap has decreased from $11.00M to $4.55M, a decrease of -58.60%. That is a compound annual growth rate of -35.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2019 | 15.50M | 181.82% |
| Dec 31, 2018 | 5.50M | -62.84% |
| Dec 29, 2017 | 14.80M | 34.55% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |